Position in MDXH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$472,507
-$938,999 QoQ
Shares Held
205,438
-48.0% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 51 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 74.02671365570149.ToString("F0")%
Shared 0.ToString("F0")%
None 25.973286344298526.ToString("F0")%
Common Shares in MDXH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $58,272,910 across 13 Diagnostics & Research names. MDXH ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,183,572 | $13,909,353 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
|
931,522 | $12,929,525 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
43,634 | $7,526,865 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
14,073 | $6,917,301 | |
| 5 | A |
Agilent Technologies, Inc.
|
41,202 | $4,696,203 | |
| 6 | DHR |
Danaher Corp /De/
|
14,638 | $2,775,364 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
34,562 | $2,219,571 | |
| 8 | VCYT |
Veracyte, Inc.
|
54,320 | $1,749,647 |
All Filings in MDXH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $472,507 | 205,438 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,411,506 | 395,380 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,825,831 | 392,652 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||